Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Onko İlaç is a leading Turkish pharmaceutical company specializing in the development and manufacture of high-potency products, particularly in the fields of oncology and hematology. Founded in 1987, the company operates a state-of-the-art production facility in the Gebze Organized Industrial Zone, which is one of the few in the region capable of handling cytotoxic and non-cytotoxic products in separate, dedicated lines. Their portfolio includes a wide range of generic oncology drugs, contrast agents for radiology, and supportive care treatments. Onko İlaç also provides contract manufacturing services (CMO) to global pharmaceutical partners, leveraging its EU-GMP certified facilities. The company is recognized for its significant R&D investment and its role in reducing Turkey's dependence on imported cancer medications. By focusing on high-tech pharmaceutical production, Onko İlaç plays a critical role in the Turkish healthcare sector and exports its products to numerous global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Onko Ilac San ve Tic.